How can we help?
Interested?
How can we help?
Interested?
How can we help?
Interested?
How can we help?
Interested?
Biocartis (Euronext Brussels: BCART) is an innovative molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Biocartis’ proprietary MDx Idylla™ platform is a fully automated sample-to-result, real-time PCR (Polymerase Chain Reaction) system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting. Biocartis launched the Idylla™ platform in September 2014. Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases. These areas represent respectively the fastest growing and largest segments of the MDx market worldwide. Today, Biocartis has five oncology tests and two infectious disease test on the market.
Interested?
Leuven MindGate is a premier region for Health, High-Tech and Creativity. By connecting organisations as well as individuals in a unique ecosystem, we inspire innovation, entrepreneurship and increase cross-over collaborations for the entire region's benefit.
Stay tuned and get our news in your inbox: subscribe here.
